A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide microplate a
ssay was adapted to screen for the ability of 20 host-defense peptides to i
nactivate herpes simplex virus type 1 and type 2. The procedure required mi
nimal amounts of material, was reproducible, and was confirmed with standar
d antiviral testing techniques. In screening tests, with the exception of m
elittin, a highly cytotoxic and hemolytic peptide found in bee venom, the c
t-helical peptides in our test panel (magainins, cecropins, clavanins, and
LL-37) caused little viral inactivation. Several P-sheet peptides (defensin
s, tachyplesin, and protegrins) inactivated one or both viruses, sometimes
with remarkable selectivity. Two peptides were identified as having antivir
al activity against both viruses, indolicidin (a tryptophan-rich peptide fr
om bovine neutrophils) and brevinin-1 (a peptide found in frog skin). The a
ntiviral activity of these two peptides was confirmed with standard antivir
al assays. Interestingly, the antiviral activity of brevinin-1 was maintain
ed after reduction and carboxamidomethylation, procedures that abolished it
s otherwise prominent hemolytic and cytotoxic effects.